FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050552175> ?p ?o ?g. }

• W2050552175 endingPage "70" @default.
• W2050552175 startingPage "65" @default.
• W2050552175 abstract "Aims Lanreotide is a novel synthetic somatostatin analogue. A long-acting formulation of lanreotide has been shown to be effective for the treatment of gastroentero-pancreatic hormone-producing tumours but effects on postprandial digestive and absorptive functions remain obscure. The aim of the present study was to evaluate the effects of intravenous lanreotide on gastric and biliopancreatic secretions in man as well as the absorption of nutrients and the duodeno-caecal transit time after ingestion of an homogenized meal (500 kcal, 55% carbohydrates, 15% proteins, 30% lipids). Methods Eight healthy male volunteers were studied on two occasions within a 2 weeks interval, using a perfusion method. They received in single-blind and random order continuous i.v. infusion of either placebo or lanreotide (100 μg h−1 after a bolus of 100 μg 15 min before the beginning of the study). Results Lanreotide significantly decreased gastric acid secretion (90%) for the initial 3 h period. Gastric emptying was not significantly molfied by lanreotide infusion. Compared with placebo, lanreotide almost completely abolished both bile salts and lipase responses to the meal. It largely increased the duodeno-caecal transit time and decreased significantly the duodenal absorption of carbohydrates and triglycerides. Conclusions Since lanreotide has powerful effects on gastrointestinal functions, it could be useful in the prevention or in the treatment of pancreatic and bowel fistulas as well as short bowel syndrome." @default.
• W2050552175 created "2016-06-24" @default.
• W2050552175 creator A5002541459 @default.
• W2050552175 creator A5007096310 @default.
• W2050552175 creator A5015914842 @default.
• W2050552175 creator A5036556807 @default.
• W2050552175 creator A5042262067 @default.
• W2050552175 creator A5061797696 @default.
• W2050552175 creator A5066125288 @default.
• W2050552175 date "1997-01-01" @default.
• W2050552175 modified "2023-10-09" @default.
• W2050552175 title "Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans" @default.
• W2050552175 cites W1456019232 @default.
• W2050552175 cites W1563139854 @default.
• W2050552175 cites W1585598978 @default.
• W2050552175 cites W1599415104 @default.
• W2050552175 cites W1604700543 @default.
• W2050552175 cites W1722449441 @default.
• W2050552175 cites W1755456613 @default.
• W2050552175 cites W1898944809 @default.
• W2050552175 cites W1906106142 @default.
• W2050552175 cites W1964601611 @default.
• W2050552175 cites W1974384535 @default.
• W2050552175 cites W1974492914 @default.
• W2050552175 cites W1994435086 @default.
• W2050552175 cites W1997385594 @default.
• W2050552175 cites W1998933514 @default.
• W2050552175 cites W2021353890 @default.
• W2050552175 cites W2031889440 @default.
• W2050552175 cites W2037147471 @default.
• W2050552175 cites W2055894260 @default.
• W2050552175 cites W2056181804 @default.
• W2050552175 cites W2056532487 @default.
• W2050552175 cites W2075061146 @default.
• W2050552175 cites W2076685145 @default.
• W2050552175 cites W2083962525 @default.
• W2050552175 cites W2102269371 @default.
• W2050552175 cites W2103861685 @default.
• W2050552175 cites W2114449000 @default.
• W2050552175 cites W2131455589 @default.
• W2050552175 cites W4249967383 @default.
• W2050552175 cites W57167087 @default.
• W2050552175 doi "https://doi.org/10.1111/j.1365-2125.1997.tb00139.x" @default.
• W2050552175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9056054" @default.
• W2050552175 hasPublicationYear "1997" @default.
• W2050552175 type Work @default.
• W2050552175 sameAs 2050552175 @default.
• W2050552175 citedByCount "9" @default.
• W2050552175 countsByYear W20505521752016 @default.
• W2050552175 countsByYear W20505521752018 @default.
• W2050552175 countsByYear W20505521752019 @default.
• W2050552175 countsByYear W20505521752022 @default.
• W2050552175 countsByYear W20505521752023 @default.
• W2050552175 crossrefType "journal-article" @default.
• W2050552175 hasAuthorship W2050552175A5002541459 @default.
• W2050552175 hasAuthorship W2050552175A5007096310 @default.
• W2050552175 hasAuthorship W2050552175A5015914842 @default.
• W2050552175 hasAuthorship W2050552175A5036556807 @default.
• W2050552175 hasAuthorship W2050552175A5042262067 @default.
• W2050552175 hasAuthorship W2050552175A5061797696 @default.
• W2050552175 hasAuthorship W2050552175A5066125288 @default.
• W2050552175 hasBestOaLocation W20505521751 @default.
• W2050552175 hasConcept C126322002 @default.
• W2050552175 hasConcept C134018914 @default.
• W2050552175 hasConcept C142724271 @default.
• W2050552175 hasConcept C204787440 @default.
• W2050552175 hasConcept C27081682 @default.
• W2050552175 hasConcept C2776297358 @default.
• W2050552175 hasConcept C2777433750 @default.
• W2050552175 hasConcept C2778199505 @default.
• W2050552175 hasConcept C2779306644 @default.
• W2050552175 hasConcept C2779422922 @default.
• W2050552175 hasConcept C2779609023 @default.
• W2050552175 hasConcept C2984496839 @default.
• W2050552175 hasConcept C3020479747 @default.
• W2050552175 hasConcept C43376680 @default.
• W2050552175 hasConcept C71315377 @default.
• W2050552175 hasConcept C71924100 @default.
• W2050552175 hasConcept C90924648 @default.
• W2050552175 hasConceptScore W2050552175C126322002 @default.
• W2050552175 hasConceptScore W2050552175C134018914 @default.
• W2050552175 hasConceptScore W2050552175C142724271 @default.
• W2050552175 hasConceptScore W2050552175C204787440 @default.
• W2050552175 hasConceptScore W2050552175C27081682 @default.
• W2050552175 hasConceptScore W2050552175C2776297358 @default.
• W2050552175 hasConceptScore W2050552175C2777433750 @default.
• W2050552175 hasConceptScore W2050552175C2778199505 @default.
• W2050552175 hasConceptScore W2050552175C2779306644 @default.
• W2050552175 hasConceptScore W2050552175C2779422922 @default.
• W2050552175 hasConceptScore W2050552175C2779609023 @default.
• W2050552175 hasConceptScore W2050552175C2984496839 @default.
• W2050552175 hasConceptScore W2050552175C3020479747 @default.
• W2050552175 hasConceptScore W2050552175C43376680 @default.
• W2050552175 hasConceptScore W2050552175C71315377 @default.
• W2050552175 hasConceptScore W2050552175C71924100 @default.
• W2050552175 hasConceptScore W2050552175C90924648 @default.
• W2050552175 hasIssue "1" @default.
• W2050552175 hasLocation W20505521751 @default.

• next